Health
NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms – News-Medical.net
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, the ACTIV-6 trial aims to provide evidence-based…
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News13 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track